SUPPLEMENT

FY2026 — Five-year review

FY2026PDF · 4 pages121 KB
FIVE-YEAR
REVIEWfor the year ended 30 June 2026

-- 1 of 4 --

Normalised five-year review
R million
Year ended 30 June
Growth %
Total Compound
growth %
Continuing*
2022 2023 2024 2025 2026 2025 2026
Statement of financial position – normalised
Total assets 1 999 645 2 295 274 2 366 118 2 585 440 2 736 791 8 2 070 223 2 227 792 8
Core lending advances 1 311 441 1 511 037 1 597 898 1 699 002 1 786 492 8 1 288 295 1 373 680 7
Gross advances before impairments 1 382 058 1 590 447 1 665 706 1 803 827 1 958 774 9 1 393 120 1 545 962 11
Total impairments 47 734 51 072 54 165 55 188 56 537 4 48 903 51 149 5
Gross advances (net of impairments) 1 334 324 1 539 375 1 611 541 1 748 639 1 902 237 9 1 344 217 1 494 813 11
Stage 3/NPLs 50 886 57 432 67 840 74 484 75 977 11 60 602 63 476 5
Deposits and debt funding 1 655 972 1 923 103 2 003 151 2 181 874 2 321 420 9 1 726 828 1 869 923 8
Capital and reserves attributable to equityholders of the group 164 857 181 451 197 809 221 721 229 476 9 170 437 186 616 9
Income statement – normalised
Net interest income before impairment of advances 67 856 78 615 86 105 91 231 97 134 9 77 002 83 401 8
Impairment charge (7 080) (10 949) (12 555) (14 044) (15 005) 21 (13 654) (13 980) 2
Total non-interest revenue 48 362 52 393 55 295 58 463 65 697 8 58 438 65 604 12
Operational non-interest revenue 46 856 51 900 52 873 55 522 63 543 8 55 514 63 472 14
Share of profit of associates and joint ventures after tax 1 506 493 2 422 2 941 2 154 9 2 924 2 132 (27)
Operating expenses (61 024) (67 320) (71 106) (73 042) (78 895) 7 (65 751) (71 552) 9
Earnings attributable to ordinary equityholders of the group 32 663 36 634 40 406 44 011 48 409 10 39 415 44 461 13
Key ratios – normalised
ROE (%) 20.6 21.1 21.3 21.0 21.5 24.3 24.9
ROA (%) 1.69 1.71 1.73 1.78 1.82 1.99 2.07
Cost-to-income ratio (%) 52.5 51.4 50.3 48.8 48.5 48.5 48.0
Credit loss ratio (%) – core lending advances 0.56 0.78 0.81 0.85 0.86 1.08 1.05
Stage 3/NPLs as a % of core lending advances 3.88 3.80 4.25 4.38 4.25 4.70 4.62
Diversity ratio (%) 41.6 40.0 39.1 39.1 40.3 43.1 44.0
Share statistics – normalised
Price earnings ratio (times) 10.7 10.5 11.4 9.6 11.2
Price-to-book ratio (times) 2.1 2.1 2.2 1.9 2.4
Market capitalisation 349 864 384 250 431 370 424 582 545 579 12
Closing share price (cents) 6 237 6 850 7 690 7 569 9 726 12
* Continuing results excludes the UK operations. Refer to page 22 of the FirstRand analysis of financial results booklet available at https://www.firstrand.co.za/investors/integrated-reporting-hub/financial reporting/ for more information.
01
FIRSTRAND GROUP NORMALISED FIVE-YEAR REVIEW

-- 2 of 4 --

Normalised five-year review continued
R million
Year ended 30 June
Growth %
Total Compound
growth %
Continuing*
2022 2023 2024 2025 2026 2025 2026
Exchange rates
$/R
– Closing 16.41 18.84 18.22 17.78 16.37 17.78 16.37
– Average 15.19 17.73 18.71 18.15 16.88 18.15 16.88
£/R
– Closing 19.95 23.95 22.99 24.36 21.67 24.36 21.67
– Average 20.21 21.31 23.55 23.49 22.66 23.49 22.66
Statement of financial position ($ million)** – normalised
Total assets 121 855 121 830 129 864 145 413 167 183 8 116 435 136 090 17
Core lending advances 79 917 80 204 87 700 95 557 109 132 8 72 458 83 914 16
Gross advances before impairments 84 220 84 419 91 422 101 463 119 656 9 78 353 94 439 21
Total impairments 2 909 2 711 2 973 3 104 3 454 4 2 750 3 125 14
Gross advances (net of impairments) 81 312 81 708 88 449 98 349 116 202 9 75 603 91 314 21
Stage 3/NPLs 3 101 3 048 3 723 4 189 4 641 11 3 408 3 878 14
Deposits and debt funding 100 912 102 076 109 942 122 715 141 809 9 97 122 114 229 18
Capital and reserves attributable to equityholders of the group 10 046 9 631 10 857 12 470 14 018 9 9 586 11 400 19
Income statement ($ million)# – normalised
Net interest income before impairment of advances 4 467 4 434 4 602 5 027 5 754 7 4 243 4 941 16
Impairment charge (466) (618) (671) (774) (889) 18 (752) (828) 10
Total non-interest revenue 3 184 2 955 2 955 3 221 3 892 5 3 220 3 886 21
Operational non-interest revenue 3 085 2 927 2 826 3 059 3 764 5 3 059 3 760 23
Share of profit of associates and joint ventures after tax 99 28 129 162 128 7 161 126 (22)
Operating expenses (4 017) (3 797) (3 800) (4 024) (4 674) 4 (3 623) (4 239) 17
Earnings attributable to ordinary equityholders of the group 2 150 2 066 2 160 2 425 2 868 7 2 172 2 634 21
Statement of financial position (£ million)** – normalised
Total assets 100 233 95 836 102 919 106 135 126 294 6 84 985 102 805 21
Core lending advances 65 736 63 091 69 504 69 746 82 441 6 52 886 63 391 20
Gross advances before impairments 69 276 66 407 72 454 74 049 90 391 7 57 189 71 341 25
Total impairments 2 393 2 132 2 356 2 266 2 609 2 2 008 2 360 18
Advances (net of impairments) 66 883 64 275 70 098 71 783 87 782 7 55 181 68 981 25
Stage 3/NPLs 2 551 2 398 2 951 3 058 3 506 8 2 488 2 929 18
Deposits and debt funding 83 006 80 297 87 131 89 568 107 126 7 70 888 86 291 22
Capital and reserves attributable to equityholders of the group 8 264 7 576 8 604 9 102 10 590 6 6 997 8 612 23
Income statement (£ million)# – normalised
Net interest income before impairment of advances 3 358 3 689 3 656 3 884 4 287 6 3 278 3 681 12
Impairment charge (350) (514) (533) (598) (662) 17 (581) (617) 6
Total non-interest revenue 2 393 2 459 2 348 2 489 2 899 5 2 488 2 895 16
Operational non-interest revenue 2 318 2 435 2 245 2 364 2 804 5 2 363 2 801 19
Share of profit of associates and joint ventures after tax 75 23 103 125 95 6 124 94 (24)
Operating expenses (3 019) (3 159) (3 019) (3 109) (3 482) 4 (2 799) (3 158) 13
Earnings attributable to ordinary equityholders of the group 1 616 1 719 1 716 1 874 2 136 7 1 678 1 962 17
* Continuing results excludes the UK operations. Refer to page 22 of the FirstRand analysis of financial results booklet available at https://www.firstrand.co.za/investors/integrated-reporting-hub/financial reporting/ for more information.
** The statement of financial position is converted using the closing rates as disclosed for each reporting year.
# The income statement is converted using the average rate as disclosed for each reporting year.
02
FIRSTRAND GROUP NORMALISED FIVE-YEAR REVIEW

-- 3 of 4 --

www.firstrand.co.za

-- 4 of 4 --